Finance

Beta
Lists
IRMD:NASDAQ
Iradimed Corp
US$ ९३.९६
+०.१०%
(+०.०९०) 1D
US$ ९३.९६
०.००% (०.००)
After hours
Closed: जुन २६, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRMD...
Open
US$ ९४.१९
High
US$ ९५.७५
Low
US$ ९२.०४
Mkt. cap
१.२० अरब
Avg. vol.
१.४५ लाख
Volume
२.८२ लाख
Dividend
०.८५%
Quarterly dividend
US$ ०.२०
Ex-dividend date
२०२६ मे १५
P/E ratio
५१.२०
52-wk high
US$ १०७.९०
52-wk low
US$ ५५.११
EPS
US$ १.८४
Beta
०.८९
Shares outstanding
१.२८ करोड
No. of employees
१६६
Open
US$ ९४.१९
High
US$ ९५.७५
Low
US$ ९२.०४
Mkt. cap
१.२० अरब
Avg. vol.
१.४५ लाख
Volume
२.८२ लाख
Dividend
०.८५%
Quarterly dividend
US$ ०.२०
Ex-dividend date
२०२६ मे १५
P/E ratio
५१.२०
52-wk high
US$ १०७.९०
52-wk low
US$ ५५.११
EPS
US$ १.८४
Beta
०.८९
Shares outstanding
१.२८ करोड
No. of employees
१६६
News stories
From sources across the web
About Iradimed Corp
CEO-
Employees१६६
Founded१९९२
Headquartersअरल्यान्दो, फ्लोरिडा, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to IRMD in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for IRMD in the last 3 months
Highest
Current US$ ९३.९६
US$ ११६.०० (+२३.४६%)
Average
US$ ११६.०० (+२३.४६%)
Lowest
US$ ११६.०० (+२३.४६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
US$ ११६.००
+२३.५%
04/02/2026
Frank Takkinen
Lake Street
Buy
Reiterated
US$ १२०.००
+२७.७%
02/11/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
US$ १२०.००
+२७.७%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
२.०४ करोड
२.१२ करोड
२.२७ करोड
२.२० करोड
Cost of goods sold
४४.५४ लाख
४७.०८ लाख
५६.६० लाख
५१.६५ लाख
Cost of revenue
४४.५४ लाख
४७.०८ लाख
५६.६० लाख
५१.६५ लाख
Research and development expenses
८.६८ लाख
६.७४ लाख
७.७५ लाख
९.५६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८२.९९ लाख
८९.८६ लाख
९१.६३ लाख
८६.२१ लाख
Operating expense
९१.६७ लाख
९६.६१ लाख
९९.३८ लाख
९५.७७ लाख
Total operating expenses
१.३६ करोड
१.४४ करोड
१.५६ करोड
१.४७ करोड
Operating income
६७.८८ लाख
६८.३४ लाख
७०.९४ लाख
७२.३७ लाख
Other non operating income
५.३९ लाख
४.६४ लाख
-१५.१७ लाख
५.३२ लाख
EBT including unusual items
७३.२७ लाख
७२.९८ लाख
७७.९१ लाख
७७.६९ लाख
EBT excluding unusual items
७३.२७ लाख
७२.९८ लाख
७५.८८ लाख
७७.६९ लाख
Income tax expense
१५.५३ लाख
१७.२१ लाख
१३.४९ लाख
१९.५१ लाख
Effective tax rate
२१.२०%
२३.५८%
१७.३१%
२५.११%
Other operating expenses
-
-
-
-
Net income
५७.७४ लाख
५५.७७ लाख
६४.४२ लाख
५८.१८ लाख
Net profit margin
२८.२९%
२६.३०%
२८.३९%
२६.४७%
Earnings per share
०.४९
०.४७
०.५४
०.४९
Interest and investment income
-
-
२०.०९ लाख
-
Interest expense
-
-
-
-
Net interest expenses
-
-
२०.०९ लाख
-
Depreciation and amortization charges
-
-
-
-
EBITDA
६९.९५ लाख
७२.१७ लाख
७४.७४ लाख
७६.९२ लाख
Gain or loss from assets sale
१.१६ हजार
३२.९९ हजार
२.८५ हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of IRMD
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more